Eva Riechert

Heidelberg University — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

10h-index493citations21works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(8), RNA Research and Splicing(7), RNA and protein synthesis mechanisms(5), Cardiac Fibrosis and Remodeling(5), Ubiquitin and proteasome pathways(4)

Publications21 total

Cpeb4 regulates cardiomyocyte growth and function by the modulating the expression of Zeb1
Journal of Molecular and Cellular Cardiology·2022
Translational control of Y-box 1 via mTOR pathway during pathological cardiac hypertrophy
Journal of Molecular and Cellular Cardiology·2022
mTORC1-dependent translational control of Cand2 leads to transcriptional reprogramming in diseased cardiac myocytes
Journal of Molecular and Cellular Cardiology·2022
Analysis of myocardial cellular gene expression during pressure overload reveals matrix based functional intercellular communication
iScience·2022· 29 citedOpen Access
Muscle‐specific Cand2 is translationally upregulated by mTORC1 and promotes adverse cardiac remodeling
EMBO Reports·2021· 21 citedOpen Access
Corrigendum: A Multi-Network Comparative Analysis of Transcriptome and Translatome Identifies Novel Hub Genes in Cardiac Remodeling
Frontiers in Genetics·2021Open Access
Identification of dynamic RNA-binding proteins uncovers a Cpeb4-controlled regulatory cascade during pathological cell growth of cardiomyocytes
Cell Reports·2021· 30 citedOpen Access
Muscle specific translational control of Cand2 by mTORC1 regulates adverse cardiac remodeling
2020Open Access
A Multi-Network Comparative Analysis of Transcriptome and Translatome Identifies Novel Hub Genes in Cardiac Remodeling
Frontiers in Genetics·2020· 7 citedOpen Access
A multi-network comparative analysis of transcriptome and translatome in cardiac remodeling
2020· 1 cited
CITED4 Protects Against Adverse Remodeling in Response to Physiological and Pathological Stress
Circulation Research·2020· 59 citedOpen Access
Saraf-dependent activation of mTORC1 regulates cardiac growth
Journal of Molecular and Cellular Cardiology·2020· 15 cited
Identification of Dynamic RNA-Binding Proteins Uncovers a Cpeb4-Controlled Regulatory Cascade During Pathological Cell Growth of Cardiomyocytes
SSRN Electronic Journal·2020· 2 citedOpen Access
PRAS40 suppresses atherogenesis through inhibition of mTORC1-dependent pro-inflammatory signaling in endothelial cells
Scientific Reports·2019· 21 citedOpen Access
<scp>TIP</scp> 30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation
EMBO Molecular Medicine·2019· 26 citedOpen Access
Abstract 632: MTOR-Proteasome Imbalance Upon Deletion of Pras40 Inhibits Cardiac Growth but Results in Cardiac Failure
Circulation Research·2019
Monitoring Cell-Type–Specific Gene Expression Using Ribosome Profiling In Vivo During Cardiac Hemodynamic Stress
Circulation Research·2019· 104 citedOpen Access
m<sup>6</sup>A-mRNA methylation regulates cardiac gene expression and cellular growth
Life Science Alliance·2019· 137 citedOpen Access
Abstract 20269: The Stress Response Transcription Factor ATF6 is Necessary for Compensatory Cardiac Hypertrophy
Circulation·2017
Genomic structural variations lead to dysregulation of important coding and non‐coding <scp>RNA</scp> species in dilated cardiomyopathy
EMBO Molecular Medicine·2017· 41 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Mirko Völkers(20), Hugo A. Katus(18), Lonny Jürgensen(13), Christoph Dieterich(11), Shirin Doroudgar(11), Christoph P. Hofmann(10), Etienne Boileau(9), Vivien Kmietczyk(8), Eshita Varma(8), Verena Kamuf‐Schenk(8), Thanh Cao Ho(7), Agnieszka Górska(6), Ellen Malovrh(5), Jana Burghaus(5), Clara Sandmann(4), Norbert Frey(4), Brandon Malone(3), Mandy Rettel(3), Frank Stein(3), Claudia Stroh(3)